Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 316

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 316
---
TOTAL OPERATING EXPENSES781,818 717,048 740,659 INCOME (LOSS) FROM OPERATIONS42,964 22,825 (42,898)INTEREST EXPENSE, NET(95,753)(95,219)(66,375)OTHER EXPENSE, NET(13,223)(5,905)(5,136)LOSS BEFORE INCOME TAXES(66,012)(78,299)(114,409)(PROVISION) BENEFIT FOR INCOME TAXES(51,676)48,644 40,123 NET LOSS$(117,688)$(29,655)$(74,286)NET LOSS PER SHARE  Basic$(4.83)$(1.23)$(3.11)Diluted$(4.83)$(1.23)$(3.11)WEIGHTED AVERAGE NUMBER OF SHARES  Basic24,388 24,091 23,868 Diluted24,388 24,091 23,868 

The accompanying notes are an integral part of these consolidated financial statements.

63

ICU MEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Amounts in thousands)

 Year ended December 31, 202420232022NET LOSS$(117,688)$(29,655)$(74,286)Other comprehensive loss, net of tax:Cash flow hedge adjustments, net of tax of $0, $(5,951) and $12,941 for the years ended December 31, 2024, 2023 and 2022, respectively(16,162)(18,895)41,016 Foreign currency translation adjustment, net of tax of $0 for all periods (70,158)46,189 (103,928)Other adjustments, net of tax of $0 for all periods— 603 1,203 Other comprehensive (loss) income, net of tax(86,320)27,897 (61,709)COMPREHENSIVE LOSS$(204,008)$(1,758)$(135,995)

The accompanying notes are an integral part of these consolidated financial statements.

64

ICU MEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Amounts in thousands)

      Common StockAdditional Paid-In CapitalTre